Large genomic studies of individuals with autism spectrum disorders (ASD) have revealed approximately 100-200 high risk genes. However, whether these genes function in similar or different signaling networks in brain cells (neurons) remains poorly studied. We are using proteomic technology to build an ASD-associated signaling network map as a resource for the Autism research community. This resource can be used to study Autism risk genes and understand how pathways are convergent, and how patient mutations change the interaction profile. In this presentation, we will present how we developed a pipeline using neurons to build protein-protein interaction profiles. We detected previously unknown interactions between different ASD risk genes that have never been linked together before, and for some genes, we identified new signaling pathways that have not been previously reported. This resource will be available to the research community and will foster collaborations between ASD researchers to help accelerate therapeutics for ASD and related disorders.

Emerging genetic studies of late-onset Alzheimer’s Disease implicate the brain’s resident macrophages in the pathogenesis of AD. More than half the risk genes associated with late-onset AD are selectively expressed in microglia and peripheral myeloid cells; yet we know little about the underlying biology or how myeloid cells contribute to AD pathogenesis. Using single-cell RNA sequencing and spatial transcriptomics we identified molecular signatures that can be used to localize and monitor distinct microglia functional states in the human and mouse brain. Our results show that microglia assume diverse functional states in development, aging and injury, including populations corresponding to known microglial functions including proliferation, migration, inflammation, and synaptic phagocytosis. We identified several innate immune pathways by which microglia recognize and prune synapses during development and in models of Alzheimer’s disease, including the classical complement cascade. Illuminating the mechanisms by which developing synaptic circuits are sculpted is providing important insight on understanding how to protect synapses in Alzheimer’s and other neurodegenerative diseases of synaptic dysfunction.

Autism spectrum disorder (ASD) is a neurodevelopmental disorder affecting up to 1% of the population. Over the past few years, large-scale genomic studies have identified hundreds of genetic loci associated with liability to ASD. It is now time to translate these genetic discoveries into functional studies that can help us understand convergences and divergences across risk genes, and build pre-clinical cell and animal models. In this seminar, I will discuss some of the most recent findings on the genetic risk architecture of ASD. I will then expand on our work on biomarkers discovery and neurodevelopmental analyses in two rare genetic conditions associated with ASD: ADNP and DDX3X syndrome.

Plasticity shapes the brain during development, and mechanisms of plasticity continue into adulthood to enable learning and memory. Nearly all brain functions are influenced by past events, reinforcing the view that the confluence of plasticity and computation in the same circuit elements is a core component of biological intelligence. My laboratory studies plasticity in the cerebral cortex during development, and plasticity during behaviour that is manifest as cortical dynamics. I will describe how cortical plasticity is implemented by learning rules that involve not only Hebbian changes and synaptic scaling but also dendritic renormalization. By using advanced techniques such as optical measurements of single-synapse function and structure in identified neurons in awake behaving mice, we have recently demonstrated locally coordinated plasticity in dendrites whereby specific synapses are strengthened and adjacent synapses with complementary features are weakened. Together, these changes cooperatively implement functional plasticity in neurons. Such plasticity relies on the dynamics of activity-dependent molecules within and between synapses. Alongside, it is increasingly clear that risk genes associated with neurodevelopmental disorders disproportionately target molecules of plasticity. Deficits in renormalization contribute fundamentally to dysfunctional neuronal circuits and computations, and may be a unifying mechanistic feature of these disorders.